Kevin Y Stein1, Logan Froese2, Alwyn Gomez3,4, Amanjyot Singh Sainbhi2, Carleen Batson4, Francois Mathieu5, Frederick A Zeiler2,3,4,6,7. 1. Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, Canada. steink34@myumanitoba.ca. 2. Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, Canada. 3. Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. 4. Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada. 5. Interdepartmental Division of Critical Care, Department of Medicine, University of Toronto, Toronto, Canada. 6. Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. 7. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Impaired cerebrovascular reactivity following moderate/severe traumatic brain injury (TBI) has emerged as a key potential driver of morbidity and mortality. However, the major contributions to the literature so far have been solely focused on single point measures of long-term outcome. Therefore, it remains unknown whether cerebrovascular reactivity impairment, during the acute phase of TBI, is associated with failure to improve in outcome across time. METHODS: Cerebrovascular reactivity was measured using three intracranial pressure-based surrogate metrics. For each patient, % time spent above various literature-defined thresholds was calculated. Patients were dichotomized based on outcome transition into Improved vs Not Improved between 1 and 3 months, 3 and 6 months, and 1 and 6 months, based on the Glasgow Outcome Scale-Extended (GOSE). Univariate and multivariable logistic regression analyses were performed, adjusting for the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) variables. RESULTS: Seventy-eight patients from the Winnipeg Acute TBI Database were included in this study. On univariate logistic regression analysis, higher % time with cerebrovascular reactivity metrics above clinically defined thresholds was associated with a lack of clinical improvement between 1 and 3 months and 1 and 6 months post injury (p < 0.05). These relationships held true on multivariable logistic regression analysis. CONCLUSION: Our study demonstrates that impaired cerebrovascular reactivity, during the acute phase of TBI, is associated with failure to improve clinically over time. These preliminary findings highlight the significance that cerebrovascular reactivity monitoring carries in outcome recovery association in moderate/severe TBI.
BACKGROUND: Impaired cerebrovascular reactivity following moderate/severe traumatic brain injury (TBI) has emerged as a key potential driver of morbidity and mortality. However, the major contributions to the literature so far have been solely focused on single point measures of long-term outcome. Therefore, it remains unknown whether cerebrovascular reactivity impairment, during the acute phase of TBI, is associated with failure to improve in outcome across time. METHODS: Cerebrovascular reactivity was measured using three intracranial pressure-based surrogate metrics. For each patient, % time spent above various literature-defined thresholds was calculated. Patients were dichotomized based on outcome transition into Improved vs Not Improved between 1 and 3 months, 3 and 6 months, and 1 and 6 months, based on the Glasgow Outcome Scale-Extended (GOSE). Univariate and multivariable logistic regression analyses were performed, adjusting for the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) variables. RESULTS: Seventy-eight patients from the Winnipeg Acute TBI Database were included in this study. On univariate logistic regression analysis, higher % time with cerebrovascular reactivity metrics above clinically defined thresholds was associated with a lack of clinical improvement between 1 and 3 months and 1 and 6 months post injury (p < 0.05). These relationships held true on multivariable logistic regression analysis. CONCLUSION: Our study demonstrates that impaired cerebrovascular reactivity, during the acute phase of TBI, is associated with failure to improve clinically over time. These preliminary findings highlight the significance that cerebrovascular reactivity monitoring carries in outcome recovery association in moderate/severe TBI.
Authors: Marcel J H Aries; Marek Czosnyka; Karol P Budohoski; Angelos G Kolias; Danila K Radolovich; Andrea Lavinio; John D Pickard; Peter Smielewski Journal: Neurocrit Care Date: 2012-08 Impact factor: 3.210
Authors: Francis Bernard; Clare Gallagher; Donald Griesdale; Andreas Kramer; Mypinder Sekhon; Frederick A Zeiler Journal: Can J Neurol Sci Date: 2020-03-16 Impact factor: 2.104
Authors: Brenno Cabella; Joseph Donnelly; Danilo Cardim; Xiuyun Liu; Manuel Cabeleira; Peter Smielewski; Christina Haubrich; Peter J A Hutchinson; Dong-Joo Kim; Marek Czosnyka Journal: Neurocrit Care Date: 2017-08 Impact factor: 3.210
Authors: Hadie Adams; Joseph Donnelly; Marek Czosnyka; Angelos G Kolias; Adel Helmy; David K Menon; Peter Smielewski; Peter J Hutchinson Journal: PLoS Med Date: 2017-07-25 Impact factor: 11.069
Authors: Frank C Bennis; Bibi Teeuwen; Frederick A Zeiler; Jan Willem Elting; Joukje van der Naalt; Pietro Bonizzi; Tammo Delhaas; Marcel J Aries Journal: Neurocrit Care Date: 2020-10 Impact factor: 3.210